INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential.

Slides:



Advertisements
Similar presentations
DC Responses Received WA OR ID MT WY CA NV UT CO AZ NM AK HI TX ND SD NE KS OK MN IA MO AR LA WI IL MI IN OH KY TN MS AL GA FL SC NC VA WV PA NY VT NH.
Advertisements

Exhibit 1. Premiums for Family Coverage, by State, 2011 Source: 2011 Medical Expenditure Panel Survey–Insurance Component. Dollars U.S. average = $15,022.
THE COMMONWEALTH FUND Millions of uninsured Source: Income, Poverty, and Health Insurance Coverage in the United States: United States Census Bureau,
Figure 1 K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Dual Eligibles: The Basics Barbara Lyons, Ph.D. Director, Kaiser Commission on.
Background Information on the Newspoets Total Number: 78 active newspoets. 26 (of the original 36) newspoets from returned this year.
Medicaid Enrollment of New Eligibles in Expansion States, by Party Affiliation of Governor New Eligibles as a Percent of Total Medicaid Enrollment, FY.
Essential Health Benefits Benchmark Plan Selection, as of October 2012
Uninsured Non-Elderly Adult Rate Increased from 17. 8% to 20
Medicaid Eligibility for Working Parents by Income, January 2013
WA OR ID MT ND WY NV 23% CA UT AZ NM 28% KS NE MN MO WI TX 31% IA IL
Medicaid Enrollment of New Eligibles in Expansion States, by Party Affiliation of Governor New Eligibles as a Percent of Total Medicaid Enrollment, as.
Medicaid Enrollment of New Eligibles in Expansion States, by Party Affiliation of Governor New Eligibles as a Percent of Total Medicaid Enrollment, as.
House price index for AK
WY WI WV WA VA VT UT TX TN SD SC RI PA OR* OK OH ND NC NY NM* NJ NH
WY WI WV WA VA VT UT TX TN SD SC RI PA OR* OK OH ND NC NY NM* NJ NH
Children's Eligibility for Medicaid/CHIP by Income, January 2013
Medicaid Income Eligibility Levels for Other Adults, January 2017
NJ WY WI WV WA VA VT UT TX TN SD SC RI PA OR OK OH ND NC NY NM NH NV
The State of the States Cindy Mann Center for Children and Families
Avaya Consultant Relations Program
Expansion states with Republican governors outnumber expansion states with Democratic governors, January WY WI WV◊ WA VA VT UT TX TN SD SC RI PA.
Share of Births Covered by Medicaid, 2006
Non-Citizen Population, by State, 2011
Status of State Medicaid Expansion Decisions
Share of Women Ages 18 – 64 Who Are Uninsured, by State,
Coverage of Low-Income Adults by Scope of Coverage, January 2013
WY WI WV WA VA* VT UT TX TN SD SC RI PA OR* OK OH ND NC NY NM* NJ NH
WY WI WV WA VA VT UT TX TN SD SC RI PA OR* OK OH ND NC NY NM* NJ NH
Mobility Update and Discussion as of March 25, 2008
IAH CONVERSION: ELIGIBLE BENEFICIARIES BY STATE
WAHBE Brokers / QHPs across the country as of
State Health Insurance Marketplace Types, 2015
State Health Insurance Marketplace Types, 2018
HHGM CASE WEIGHTS Early/Late Mix (Weighted Average)
Status of State Medicaid Expansion Decisions
Percent of Women Ages 19 to 64 Uninsured by State,
Status of State Medicaid Expansion Decisions
10% of nonelderly uninsured 26% of nonelderly uninsured
22% of nonelderly uninsured 10% of nonelderly uninsured
Medicaid Income Eligibility Levels for Parents, January 2017
State Health Insurance Marketplace Types, 2017
S Co-Sponsors by State – May 23, 2014
WY WI WV WA VA VT UT* TX TN SD SC RI PA OR* OK OH ND NC NY NM* NJ NH
Seventeen States Had Higher Uninsured Rates Than the National Average in 2013; Of Those, 11 Have Yet to Expand Eligibility for Medicaid AK NH WA VT ME.
Employer Premiums as Percentage of Median Household Income for Under-65 Population, 2003 and percent of under-65 population live where premiums.
Employer Premiums as Percentage of Median Household Income for Under-65 Population, 2003 and percent of under-65 population live where premiums.
State Ranking on Equity Dimension
Cathy Schoen Senior Vice President The Commonwealth Fund
Average annual growth rate
Estimated Total U.S. ESRD Costs, 1997
Market Share of Two Largest Health Plans, by State, 2006
Uninsured Rate Among Adults Ages 19–64, 2008–09 and 2019
Percent of Children Ages 0–17 Uninsured by State
Current Status of State Medicaid Expansion Decisions
How State Policies Limiting Abortion Coverage Changed Over Time
United States: age distribution family households and family size
Premiums for Family Coverage, by State, 2011
Status of State Medicaid Expansion Decisions
Employer Premiums as Percentage of Median Household Income for Under-65 Population, 2003 and percent of under-65 population live where premiums.
Percent of Adults Ages 18–64 Uninsured by State
Uninsured Nonelderly Adult Rate Has Increased from Percent to 20
Status of State Medicaid Expansion Decisions
10% of nonelderly uninsured 26% of nonelderly uninsured
WY WI WV WA VA VT UT* TX TN SD SC RI PA OR* OK OH ND NC NY NM* NJ NH
WY WI WV WA VA VT UT* TX TN SD SC RI PA OR* OK OH ND NC NY NM* NJ NH
Current Status of State Individual Marketplace and Medicaid Expansion Decisions, as of September 30, 2013 WY WI WV WA VA VT UT TX TN SD SC RI PA OR OK.
Status of State Medicaid Expansion Decisions
Income Eligibility Levels for Children in Medicaid/CHIP, January 2017
WY WI WV WA VA VT UT TX TN SD SC RI PA OR OK OH ND NC NY NM NJ NH NV
22% of nonelderly uninsured 10% of nonelderly uninsured
Presentation transcript:

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 1 Factors Influencing Prescription Drug Trend within Medicare Sharon Glave Frazee, PhD., MPH Michael Looney, MBA (ARS Response Card: Channel 41)

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 2 Disclosure “I, Sharon Frazee and Michael Looney, are employees of Express Scripts, Inc. which provides Medicare drug benefit management services. The research presented herein was funded solely by Express Scripts, Inc.”

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 3 Learning Objectives Analyze pharmacy cost and utilization trends in a Medicare population compared to those in a commercially insured population Identify the physician characteristics associated with a higher Generic Fill Rate

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 4  First Drug Trend Report  Annual Outcomes Conference  Over 70 Peer-Reviewed Articles  Award-Winning Research Express Scripts Research 25 Year Proven History

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 5 Challenging Intuition with Science “Implementing a PA for PPIs in a Medicaid population will lead to unintended medical consequences.” “Implementation of 3-tier copayments will lead to increased medical costs.”

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 6 Background Nationwide there are over 47 million (and growing) Medicare beneficiaries 1 29 million Medicare beneficiaries enrolled in Part D 2 Prescription medications represent 12% of Medicare spending January 2011 – first of the Baby Boomers turned age 65 Express Scripts manages benefits for over 2 million Medicare beneficiaries (57% MADP, 28% PDP, 15% Other (EGWP, Secondary to Part D and PACE) 1 Kaiser Family Foundation: State Health Facts Kaiser Family Foundation: The Medicare Prescription Drug Benefit November Available at

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 7 7 Express Scripts Medicare Trend: Therapy Class Utilization Trend Cost TrendTotal Trend Diabetes 5.0%5.4%10.7% High Blood Pressure 2.9%-15.4%-12.9% High Cholesterol 4.4%-0.2%4.2%

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 8 Medicare Trend vs. Commercial Trend - Traditional Therapy Class Medicare TrendCommercial Trend UtilizationCostTotalUtilizationCostTotal Diabetes 5.0%5.4%10.7% -0.6%7.5%7.0% High Blood Pressure 2.9%-15.4%-12.9% -0.6%-9.0%-9.5% High Cholesterol 4.4%-0.2%4.2% -1.6%4.1%2.5% Medicare Cost trend is lower than Commercial Cost Trend Generic medications played a key role

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 9 9 Generic Pipeline: More Than $65 Billion Over Five Years

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 10 Cost Differential – Brand vs. Generic Therapy ClassBrand vs. Generic Average Cost/Rx Differential GFR Diabetes $ % High Blood Pressure $ % High Cholesterol $ % All Drugs $ %

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 11 Top 10 Traditional Medications Ranked by PMPY Cost 2011 DrugTherapy Class PLAVIXBLOOD MODIFYING ADVAIR DISKUSASTHMA LIPITORHIGH BLOOD CHOLESTEROL SEROQUELMENTAL/NEURO DISORDERS CRESTORHIGH BLOOD CHOLESTEROL ACTOSDIABETES SPIRIVACOPD OMEPRAZOLEULCER DISEASE JANUVIADIABETES SIMVASTATINHIGH BLOOD CHOLESTEROL

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 12 Top Medications by Disease Category: Ranked by PMPY Utilization DiabetesHigh Blood Pressure High Blood Cholesterol METFORMINLISINOPRILSIMVASTATIN GLIPIZIDEAMLODIPINELOVASTATIN GLIMEPIRIDEATENOLOLPRAVASTATIN ONE TOUCH ULTRA TEST STRIPS METOPROLOL TARTRATELIPITOR GLYBURIDEENALAPRILCRESTOR

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 13 Geographic Variation Source:

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 14 Question What influence do prescriber geographic and demographic characteristics have on generic prescribing patterns?

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 15 Methodology Research Question What observable characteristics impact prescriber generic fill rate? Sample  Express Scripts Internal Data  Patients with at least 1 claim for Rx for diabetes, hypertension, dyslipidemia  Prescriber criteria: Age 23-80; >=30 Rx claims in U.S.; legally authorized to prescribe in U.S. Methods  Dependent variable: 30 day adjusted disease specific prescriber generic fill rate  Adherence was measured using the medication possession ratio (MPR)  Prescriber geographic info matched on 3 digit zip census info  Multivariate Least Squares regression

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 16 Results National Sample  Hypertension = 139,093 prescribers  Lipids = 94,057 prescribers  Diabetes = 50,605 prescribers Key Factors  Age  Gender  Medicare Penetration  Physician Household Income  Census Region  Prescriber Specialty

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 17

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 18 Hypertension Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Age 21-34Reference Category Age <.0001 Age <.0001 Age <.0001 Age <.0001 Female <.0001 Rural <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 19 Hypertension – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Medicare Patients Seen: 0% (Commercial Only)Reference Category 0% < Pct. Of Patients in Medicare <=20% % < Pct. Of Patients in Medicare <=40% < % < Pct. Of Patients in Medicare <=60% < % < Pct. Of Patients in Medicare <=80% < % < Pct. Of Patients in Medicare <=100% <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 20 Hypertension – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Average Household Income Less Than or Equal to $20,000 Reference Category Average Household Income Between $20,000 and $40, <.0001 Average Household Income Between $40,000 and $60, <.0001 Average Household Income Between $60,000 and $80, <.0001 Average Household Income Become $80,000 and $100, <.0001 Average Household Income Greater than $100, <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 21 Hypertension – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value East North Central (IN, IL, MI, OH, WI)Reference Category New England (CT, ME, MA, NH, RI, VT) <.0001 Mid Atlantic (NY, NJ, PA) <.0001 West North Central (IA, KS,MN, MO, NE, ND, SD) South Atlantic (DE, DC, FL, GA, MD, NC, SC, VA, WV) <.0001 East South Central (AL, KY, MS, TN) <.0001 West South Central (AR, LA, OK, TX) <.0001 Mountain (AZ, CO, ID, NM, MT, UT, NV, WY) <.0001 Pacific (AK, CA, HI, OR, WA) <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 22 Hypertension – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Internal MedicineReference Category Nurse Practitioners <.0001 Physician Assistant Family Doctor <.0001 Geriatric <.0001 Specialist <.0001 ER Physician <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 23

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 24 Hyperlipidemia Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Age 21-34Reference Category Age <.0001 Age <.0001 Age <.0001 Age <.0001 Female <.0001 Rural <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 25 Hyperlipidemia – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Medicare Patients Seen: 0% (Commercial Only) Reference Category 0% < Pct. Of Patients in Medicare <=20% < % < Pct. Of Patients in Medicare <=40% < % < Pct. Of Patients in Medicare <=60% < % < Pct. Of Patients in Medicare <=80% < % < Pct. Of Patients in Medicare <=100% <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 26 Hyperlipidemia – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Average Household Income Less Than or Equal to $20,000 Reference Category Average Household Income Between $20,000 and $40, Average Household Income Between $40,000 and $60, Average Household Income Between $60,000 and $80, <.0001 Average Household Income Become $80,000 and $100, <.0001 Average Household Income Greater than $100, <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 27 Hyperlipidemia – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value East North Central (IN, IL, MI, OH, WI)Reference Category New England (CT, ME, MA, NH, RI, VT) <.0001 Mid Atlantic (NY, NJ, PA) <.0001 West North Central (IA, KS,MN, MO, NE, ND, SD) <.0001 South Atlantic (DE, DC, FL, GA, MD, NC, SC, VA, WV) <.0001 East South Central (AL, KY, MS, TN) <.0001 West South Central (AR, LA, OK, TX) <.0001 Mountain (AZ, CO, ID, NM, MT, UT, NV, WY) <.0001 Pacific (AK, CA, HI, OR, WA)

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 28 Hyperlipidemia – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Internal MedicineReference Category Nurse Practitioners <.0001 Physician Assistant Family Doctor <.0001 Geriatric <.0001 Specialist <.0001 ER Physician

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 29

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 30 Diabetes Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Age 21-34Reference Category Age Age Age Age Female <.0001 Rural <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 31 Diabetes – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Medicare Patients Seen: 0% (Commercial Only) Reference Category 0% < Pct. Of Patients in Medicare <=20% % < Pct. Of Patients in Medicare <=40% < % < Pct. Of Patients in Medicare <=60% < % < Pct. Of Patients in Medicare <=80% < % < Pct. Of Patients in Medicare <=100% <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 32 Diabetes – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Average Household Income Less Than or Equal to $20,000 Reference Category Average Household Income Between $20,000 and $40, Average Household Income Between $40,000 and $60, <.0001 Average Household Income Between $60,000 and $80, <.0001 Average Household Income Become $80,000 and $100, <.0001 Average Household Income Greater than $100, <.0001

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 33 Diabetes – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value East North Central (IN, IL, MI, OH, WI)Reference Category New England (CT, ME, MA, NH, RI, VT) <.0001 Mid Atlantic (NY, NJ, PA) <.0001 West North Central (IA, KS,MN, MO, NE, ND, SD) <.0001 South Atlantic (DE, DC, FL, GA, MD, NC, SC, VA, WV) <.0001 East South Central (AL, KY, MS, TN) West South Central (AR, LA, OK, TX) <.0001 Mountain (AZ, CO, ID, NM, MT, UT, NV, WY) <.0001 Pacific (AK, CA, HI, OR, WA)

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 34 Diabetes – Cont’d Prescriber GFR, Multivariate Least Squares Regression VariableCoefficientSEp-value Internal MedicineReference Category Nurse Practitioners Physician Assistant Family Doctor Geriatric Specialist <.0001 ER Physician

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 35 Model Results – Summary Medicare Penetration IncomeGeographyUrban / Rural Hypertension GFR highest when 80% < GFR lowest at income over $100k GFR highest in New England; lowest in Mid Atlantic GFR higher in rural Lipids GFR highest when 80% < GFR lowest at income over $100k GFR highest in New England; lowest in Mid Atlantic GFR higher in rural Diabetes GFR highest when 80% < GFR lowest at income over $100k GFR highest in New England; lowest in Mid Atlantic GFR higher in rural

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 36 Conclusions Higher Generic Fill Rate for prescribers who have a high concentration of Medicare Patients Lower GFR in NY, NJ, PA relative to the rest of the country; higher in New England Higher income areas have a lower GFR Rural areas have about a 1-2 point lift in GFR relative to urban areas Specialists who prescribe diabetes and lipid medications have a lower generic fill rate.

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 37 Assessments

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 38 Assessment Question 1 Which of the following have been most useful in managing Medicare prescription drug trends? Physician prescribing Formulary management Generic medications Cost sharing

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 39 Assessment Question 2 Which of the following are physician characteristics not associated with better Generic Fill Rate? All are associated Physician Region Concentration of Medicare Patients Physician Gender

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 40 Questions?

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 41 Contact Information For more information please contact: Dr. Sharon Frazee, Vice President Research and Analytics Express Scripts Inc. Mike Looney, Senior Director Medicare and Medicaid Express Scripts Inc.

INFORMATION NOT RELEASABLE TO THE PUBLIC UNLESS AUTHORIZED BY LAW: This information has not been publicly disclosed and may be privileged and confidential. It is for internal government use only and must not be disseminated, distributed, or copied to persons not authorized to receive the information. Unauthorized disclosure may result in prosecution to the full extent of the law. 42 Presentation Evaluation Please get your ARS Response Card ready